Immune reaction in healthy organs (IMAGE)
Caption
Glucose-PEGylated avelumab increased neither the number of immune cells nor the secretion of proinflammatory cytokines in the lung, kidney, and liver. Immune related adverse event (irAE) can be prevented.
Credit
2021 Innovation Center of NanoMedicine
Usage Restrictions
All rights reserved
License
Original content